Evidence map›Paper›PMID 29367411›Full record

ReviewEuropean respiratory review : an official journal of the European Respiratory Society2018

ARDS: challenges in patient care and frontiers in research.

Lieuwe D Bos, Ignacio Martin-Loeches, Marcus J Schultz

Registry-linked trialOpen access · diamondAbstract readReview
In one paragraph

Review in European respiratory review : an official journal of the European Respiratory Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05075161 (Pirfenidone to Prevent Fibrosis in ARDS. A Randomized Controlled Trial - PIONEER), which is not on this map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05075161 phase3recruitingnot on this mapstarted 2022, after this paper: background citation

Pirfenidone to Prevent Fibrosis in ARDS. A Randomized Controlled Trial - PIONEER

TypeinterventionalSponsorUniversità Vita-Salute San RaffaeleRan2022 to 2026Enrolled130ConditionsAcute Respiratory Distress Syndrome (ARDS)ArmsPirfenidone, Placebo
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Multipotent mesenchymal stromal/stem cell-based therapies for acute respiratory distress syndrome: current progress, challenges, and future frontiers.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2024
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Indications for Proning in Acute Respiratory Distress Syndrome: Expanding the Horizon!Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Lieuwe D BosDept of Intensive Care and Laboratory of Experimental Intensive Care and Anesthesiology (LEICA), Academic Medical Center, Amsterdam, The Netherlands l.d.bos@amc.uva.nl.
Ignacio Martin-LoechesDept of Intensive Care, St James's Hospital, Dublin, Ireland.
Marcus J SchultzDept of Intensive Care and Laboratory of Experimental Intensive Care and Anesthesiology (LEICA), Academic Medical Center, Amsterdam, The Netherlands.
Academic Medical Center · NLMahidol Oxford Tropical Medicine Research Unit · THSt. James's Hospital · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review discusses the clinical challenges associated with ventilatory support and pharmacological interventions in patients with acute respiratory distress syndrome (ARDS). In addition, it discusses current scientific challenges facing researchers when planning and performing trials of ventilatory support or pharmacological interventions in these patients.Noninvasive mechanical ventilation is used in some patients with ARDS. When intubated and mechanically ventilated, ARDS patients should be ventilated with low tidal volumes. A plateau pressure <30 cmH

Indexed as

Clinical Decision-MakingDiffusion of InnovationForecastingHealth Services ResearchHumansLungPatient SelectionPulmonary MedicineRespiration, ArtificialRespiratory Distress SyndromeRespiratory System AgentsRespiratory TherapyTreatment OutcomeRespiratory System Agents

Identifiers

PMID29367411
PMCPMC9489095
OpenAlexW2784351808

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.